from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1041c/-

LFCtreatmentdescriptionclass of inhibitor

0.730

Amikacinug/mL Amikacintranslation

1.105

Cap5-10ug/mL Capreomycintranslation

1.102

Rox10-50 ug/mL Roxithromycintranslation

0.193

SM2-5 ug/mL Streptomycintranslation

0.054

Tet5-10 ug/mL Tetracyclinetranslation

-0.723

Rif0.2-5ug/mL Rifampicintranscription

-0.057

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.151

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.306

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.717

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.008

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.697

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.089

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.323

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.974

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.572

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.616

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.252

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.540

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.133

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.242

KCN5-20 ug/mL Potassium cyaniderespiration

-0.920

NaN30.2-2 mM Sodium aziderespiration

0.239

Nigericin50 uM Nigericinrespiration

-0.924

TRC10-150 ug/mL Triclosanrespiration

0.164

TRZ10-25 ug/mL Thioridazinerespiration

1.168

Valinomycin0.5-10 uM Valinomycinrespiration

0.543

ZnSO42 mM ZnSO4respiration

-0.281

menadione6-10 ug/mL Menadionerespiration

-0.550

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.433

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.614

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.300

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.009

NRP_1Non-replicating persistence stage 1dosRassociated

0.761

Amp0.2mg/mL AmpicillincellWall

0.527

Cephalexin20-100 ug/mL CephalexincellWall

0.277

Cerulenin0.32-5 ug/mL CerulenincellWall

0.368

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.089

EMB10-20 ug/mL EthambutolcellWall

0.126

Eta12-40 ug/mL EthionamidecellWall

0.094

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.404

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.395

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.205

BZA0.12 mg/mL BenzamidearomaticAmides

0.653

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.465

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.826

H2O24 mM hydrogen peroxideDNAdamaging

0.087

Levo10 ug/mL LevofloxacinDNAdamaging

-0.698

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.364

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.231

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.026

UVUV-irradiationDNAdamaging

-1.218

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.596

Antimycin12.5-50 ug/mL Antimycin A?

0.998

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.481

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.457

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.640

PA8240.2-2 ug/mL PA-824?

1.020

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.011

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.329

Verapamil50 uM Verapamil?

0.419

mercaptoethanol2 mM 2-Mercaptoethanol?

0.587

methoxatin10-20 ug/mL Methoxatin?